Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma

In this article we describe the current use of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in trauma patients. Emphasis is placed on current uses as defined by key studies, efficacy data, and safety data. Most published studies in trauma patients are retrospective case studies and report...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohr, Alicia M, Holcomb, John B, Dutton, Richard P, Duranteau, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226122/
https://www.ncbi.nlm.nih.gov/pubmed/16221318
http://dx.doi.org/10.1186/cc3784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226122/
https://www.ncbi.nlm.nih.gov/pubmed/16221318
http://dx.doi.org/10.1186/cc3784

Ejemplares similares